Reported by Ariajegbe Sylvia Esezobor
The National Health Insurance Authority has significantly expanded its insurance support for cancer treatment, introducing a cost-sharing arrangement that shields eligible patients from 80 per cent of the cost of selected oncology medicines and providing additional financial support ranging from N400,000 to full coverage for radiotherapy patients, in a move aimed at reducing the catastrophic financial burden that cancer imposes on Nigerian households.
The measures, announced in a statement issued on Sunday to mark Breast Cancer Awareness Month, include an expanded partnership with pharmaceutical company Roche for selected oncology medicines. Under the arrangement, Roche bears 50 per cent of the cost, the NHIA contributes 30 per cent, and eligible patients pay the remaining 20 per cent. The arrangement effectively covers 80 per cent of the cost of the selected medicines for beneficiaries. The NHIA Director-General, Dr Kelechi Ohiri, said the interventions were designed to ensure that health insurance offered meaningful financial protection against high-cost illnesses rather than merely increasing enrolment figures. “The critical measure of the insurance system should no longer be the number of Nigerians carrying insurance records, but whether those records provide meaningful protection when illness strikes,” he said.
The radiotherapy component represents a significant expansion of financial protection for cancer patients. The NHIA said eligible radiotherapy patients can receive financial support ranging from N400,000 to full coverage, complementing existing benefits for cancer care. Under the revised policy, the previous N400,000 limit on radiotherapy has been removed and the former 50:50 cost-sharing arrangement eliminated. According to the NHIA, the reform is part of the authority’s ongoing strategic purchasing initiatives to reduce financial barriers and improve access to quality cancer treatment for enrollees. The support applies across a range of cancer types, with tariffs ranging from N400,000 for some procedures to N900,000 for breast, rectum, anal, cervix, uterus, soft tissue and bone cancers.
Beyond medicines and radiotherapy, the NHIA’s cancer benefit package includes a wide range of diagnostic and treatment services. Depending on the applicable benefit package, insurance programmes provide support for mammography, CT and MRI scans, bone scans, cancer-related laboratory and diagnostic tests, and radiotherapy. The benefits also include support for screening, surgery, chemotherapy and follow-up care. Other covered diagnostic services include tumour marker assays, ultrasound, histology including Pap smear, and endoscopy. Some cancer-related surgeries, including mastectomies and prostatectomies, as well as selected chemotherapy drugs, are also covered under different cost-sharing arrangements. Ohiri said more than 200 cancer patients receiving treatment at seven tertiary health institutions across the country had benefited from the medicine cost-sharing programme, and that the early experience was encouraging.
The NHIA said the measures were particularly important because of the scale of Nigeria’s cancer burden and the high out-of-pocket expenditure associated with treatment. Citing figures from the Global Cancer Observatory, the authority said Nigeria records an estimated 32,278 new breast cancer cases and 16,332 deaths from the disease annually. Breast cancer remains the most commonly diagnosed cancer among Nigerian women and one of the leading causes of cancer deaths in the country. A Federal Government disclosure in July 2026 said Nigeria accounted for about 10.5 per cent of Africa’s cancer burden, placing the country among the three most affected on the continent. The authority said treatment costs could expose families to prolonged financial pressure, particularly because advanced treatment abroad was beyond the reach of most Nigerians while locally available treatment could also be expensive.
The expansion of cancer coverage comes as national health insurance enrolment surpassed 23 million, up from about 16 million at the beginning of the current administration. The NHIA said the expanding pool provided a platform for extending interventions for cancer and other high-cost diseases. More than 2.7 million poor and vulnerable Nigerians have also been supported through the Basic Health Care Provision Fund. The authority acknowledged, however, that most Nigerians remained outside the health insurance system, and that achieving universal health coverage would require continued expansion of enrolment and sustained investment in the health sector.
The cancer interventions complement the Federal Government’s broader cancer prevention and treatment programme under the Federal Ministry of Health and Social Welfare. Nigeria is implementing the National Cancer Control Plan 2026–2030, which covers prevention, early detection, diagnosis, treatment and palliative care. The NHIA said its interventions were aligned with the plan’s objectives and would contribute to reducing the financial barriers that prevent many Nigerians from accessing timely and effective cancer care. The authority also emphasised that the partnership with Roche demonstrated the potential of collaboration between government, insurers, healthcare providers and pharmaceutical companies to reduce the financial burden associated with high-cost diseases.
Reactions to the expanded coverage have been largely positive, with health sector stakeholders describing the measures as a significant step towards reducing the financial toxicity of cancer treatment. The University of Nigeria Teaching Hospital, which has benefited from the NHIA-Roche partnership, said the collaboration had greatly subsidised the cost of cancer drugs and treatment for patients, reducing the financial burden on families and improving access to care. The NHIA said its interventions were producing measurable results, including a 93 per cent increase in capitation payments and a 378 per cent rise in fee-for-service reimbursements, reforms designed to enable providers to invest in personnel, equipment and infrastructure while delivering better care to patients. More than 7,500 healthcare facilities have undergone digital assessment under the SafeCare quality framework as part of efforts to institutionalise continuous quality improvement across the country.
For Nigerian cancer patients, the expanded coverage represents a tangible reduction in the cost of treatment at a time when the disease continues to claim tens of thousands of lives annually. For the NHIA, the interventions are a demonstration that insurance can provide meaningful protection when illness strikes, not merely a record of enrolment. For the broader health system, the measures reflect a growing recognition that financial protection is an essential component of effective cancer control. As Ohiri put it, coverage has to mean something when people become ill, and cancer is one of the clearest examples of why health insurance matters. The coming months will determine whether the expanded coverage translates into improved access and outcomes for the thousands of Nigerians who will be diagnosed with cancer in the year ahead.
📩 Stone Reporters News | 🌍 stonereportersnews.com
✉️ info@stonereportersnews.com | 📘 Facebook: Stone Reporters News | 🐦 X (Twitter): @StoneReportNew | 📸 Instagram: @stonereportersnews
Add comment
Comments